Methods of treating patients with an HDAC inhibitor and an mTOR inhibitor are provided.
Web www.patentalert.com
< Pharmaceutical composition having prokinetic effect
> Compositions of an Orally Active 1,2,4-Oxadiazole for Nonsense Mutation Suppression Therapy
> USE OF N-AMINOIMIDAZOLE CYTOPROTECTIVE COMPOUNDS FOR TREATING CELL DEATH AND/OR GSK-3 MEDIATED DISEASES
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT